Dabigatran bleeding risk warning issued in Japan

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1367, 2011-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Danish data highlight bleeding risk with dabigatran etexilate

By  

Reactions Weekly, Vol. 1, Iss. 1408, 2012-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Tiratricol warning issued by US FDA

By  

Inpharma, Vol. 1, Iss. 1266, 2000-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Modified HAS-BLED Score and Risk of Major Bleeding in Patients Receiving Dabigatran and Rivaroxaban: A Retrospective, Case-Control Study

By Tsu Laura V.   Berry Andrew   Wald Erin   Ehrlich Cassandra  

The Consultant Pharmacist, Vol. 30, Iss. 7, 2015-07 ,pp. : 395-402

American Society of Consultant Pharmacists

Access to resources Recommend Favorite

Warning added to UK NHS-issued PGD guidance

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 280, 2000-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Dabigatran etexilate: Bleeding in an elderly patient: case report

By  

Reactions Weekly, Vol. 1, Iss. 1432, 2012-01 ,pp. : 19-20

Adis International

Access to resources Recommend Favorite